• 专利标题:   Synthesis of functionalized nanoparticle-graphene quantum dots nanocomposites used for inhibiting bacterial growth comprises irradiating mixture of carbon source, nanocomposite core precursor powder and ligand with electromagnetic radiation.
  • 专利号:   US9931609-B1
  • 发明人:   HABIBA K, MAKAROV V, WEINER B R, MORELL G
  • 专利权人:   UNIV PUERTO RICO, HABIBA K, MAKAROV V, WEINER B R, MORELL G
  • 国际专利分类:   B82Y005/00, B01J019/12, A61K033/38, A61K047/48, B82Y040/00
  • 专利详细信息:   US9931609-B1 03 Apr 2018 B82Y-005/00 201827 Pages: 18 English
  • 申请详细信息:   US9931609-B1 US096235 11 Apr 2016
  • 优先权号:   US145559P, US096235

▎ 摘  要

NOVELTY - Synthesis of functionalized nanoparticle-graphene quantum dots nanocomposites comprises irradiating mixture containing carbon source, nanocomposite core precursor powder and ligand source with electromagnetic radiation. USE - Synthesis of functionalized nanoparticle-graphene quantum dots nanocomposites used for inhibiting bacterial growth, particularly Staphylococcus aureus and Pseudomonas aeruginosa. A determination of bacterial minimum inhibitory concentration of functionalized nanoparticle-graphene quantum dots nanocomposites, particularly silver graphene quantum dots (Ag-GQDs), was conducted by preparing bacterial suspension of Staphylococcus aureus and Pseudomonas aeruginosa having 107 CFU/mL concentration, adding 150 mu L fresh Mueller Hinton (MH) broth, 20 mu L bacterial suspension and 30 mu L different concentrations of Ag-GQDs in 96-well plate, incubating microplates at 37 degrees C for 24 hours under static conditions, and reading optical density of plate at 600 nm before and after incubation. Total inhibition of Pseudomonas aeruginosa was observed when Ag-GQDs were used at 150 mu g/mL, and of Staphylococcus aureus at 320 mu g/mL. The Ag-GQDs at 320 mu g/mL concentration have inhibition zone for Staphylococcus aureus of 12.2 plus minus 0.1 mm, and for Pseudomonas aeruginosa of 13.2 plus minus 0.2 mm. ADVANTAGE - The nanocomposites are soluble in organic and polar solutions having 2-10 nm particle size resulting to high biocompatibility.